obesity drug news today glp-1 oct 27 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 Use of diabetes and anti-obesity

If an infusion has been commenced and you subsequently decide to discontinue or require your departure, the treatment will be non-refundable

[1] CONTRAINDICATIONS History of hypersensitivity reaction to tirzepatide Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) PRECAUTIONS Kidney disease No dose adjustment is recommended in patients with any degree of renal impairment Liver disease No dose adjustment is recommended in patients with any degree of liver disease Stomach disorders Tirzepatide slows gastric emptying and is not recommended in patients with significant stomach disorders, including diabetic gastroparesis General anesthesia or deep sedation GLP-1 therapies, like tirzepatide, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures

Its role as a fat transporter supports metabolic engagement by mobilizing stored fat for energy use, potentially supporting patients in developing leaner physiques over time when combined with appropriate diet and exercise

Li, X., Hu, Y